Orthofix International N.V. Stock Upgraded (OFIX)

NEW YORK ( TheStreet) -- Orthofix International N.V (Nasdaq: OFIX) has been upgraded by TheStreet Ratings from hold to buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, attractive valuation levels, compelling growth in net income and good cash flow from operations. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

Highlights from the ratings report include:
  • OFIX's revenue growth has slightly outpaced the industry average of 5.3%. Since the same quarter one year prior, revenues slightly increased by 2.9%. Growth in the company's revenue appears to have helped boost the earnings per share.
  • Looking at where the stock is today compared to one year ago, we find that it is not only higher, but it has also clearly outperformed the rise in the S&P 500 over the same period. Although other factors naturally played a role, the company's strong earnings growth was key. Turning our attention to the future direction of the stock, it goes without saying that even the best stocks can fall in an overall down market. However, in any other environment, this stock still has good upside potential despite the fact that it has already risen in the past year.
  • The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Health Care Equipment & Supplies industry. The net income increased by 133.6% when compared to the same quarter one year prior, rising from -$35.80 million to $12.02 million.
  • Net operating cash flow has significantly increased by 160.74% to $48.97 million when compared to the same quarter last year. In addition, ORTHOFIX INTERNATIONAL NV has also vastly surpassed the industry average cash flow growth rate of -6.03%.
.

Orthofix International N.V., a medical device company, designs, develops, manufactures, markets, and distributes medical equipment used principally by musculoskeletal medical specialists for orthopedic applications. Orthofix International N.V has a market cap of $730.3 million and is part of the health care sector and health services industry. Shares are up 9.8% year to date as of the close of trading on Friday.

You can view the full Orthofix International N.V Ratings Report or get investment ideas from our investment research center.
-- Written by a member of TheStreet RatingsStaff
null